Center for Biologics Evaluation and Research

Center for Biologics Evaluation and Research

The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

60%


Total
Publications

3.7K


Total Open
Publications

2.2K


Total
Citations

149K


Open Access
Percentage

60%


Total
Publications

3.7K


Total Open
Publications

2.2K


Total
Citations

149K

Wikipedia

Website

Download

Breakdown

13% 30% 17% 40%

Publisher Open

13%

Both

30%

Other Platform Open

17%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

618

Hybrid 22%

339

No Guarantees 39%

606

Other Platform Open

Domain 95%

1.6K

Public 14%

239

Institution 12%

206

Preprint 6%

97

Other Internet 5%

78

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.6K
Europe PMC
Domain
1.4K
Semantic Scholar
Public
220
MDPI
Preprint
47
CiteSeer X
Other Internet
37
bioRxiv
Preprint
35
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
34
DOI
Other Internet
26
Zenodo
Public
15
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
15
1 / 15

Data updated 27 September 2022

Share

Share

Share